AUTOIMMUNITY
20.9K views | +14 today
AUTOIMMUNITY
Pathology, Diagnosis and Therapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
September 22, 2014 8:24 AM
Scoop.it!

Autoantibody profiling in APS. [Lupus. 2014] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE
September 21, 2014 2:16 PM
Scoop.it!

The Histidine Transporter SLC15A4 Coordinates mTOR-Dependent Inflammatory Responses and Pathogenic Antibody Production: Immunity

On the cover: Amino acid transporter SLC15A4 controls TLR7-induced autoantibody production http://t.co/YW4g1TZXsh http://t.co/QHjJn73oV8
No comment yet.
Scooped by Gilbert C FAURE
September 16, 2014 7:53 AM
Scoop.it!

Associations between thyroid autoantibody status a... [Endocrine. 2014] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE
August 29, 2014 2:55 PM
Scoop.it!

A nucleolytic lupus autoantibody is toxic to BRCA2-deficient cancer cells : Scientific Reports : Nature Publishing Group

A nucleolytic lupus autoantibody is toxic to BRCA2-deficient cancer cells : Scientific Reports : Nature Publishing Group | AUTOIMMUNITY | Scoop.it
Cancer cells with defects in DNA repair are highly susceptible to DNA-damaging agents, but delivery of therapeutic agents into cell nuclei can be challenging.
No comment yet.
Rescooped by Gilbert C FAURE from Pharma Biotech Industry Review (Krishan Maggon)
August 25, 2014 9:58 AM
Scoop.it!

Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease : Nature Reviews Rheumatology : Nature Publishing Group

Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease : Nature Reviews Rheumatology : Nature Publishing Group | AUTOIMMUNITY | Scoop.it

Antineutrophil cytoplasmic autoantibodies (ANCAs) are the probable cause of a distinct form of vasculitis that can be accompanied by necrotizing granulomatosis. Clinical and experimental evidence supports a pathogenesis that is driven by ANCA-induced activation of neutrophils and monocytes, producing destructive necrotizing vascular and extravascular inflammation. Pathogenic ANCAs can originate from precursor natural autoantibodies. Pathogenic transformation might be initiated by commensal or pathogenic microbes, legal or illegal drugs, exogenous or endogenous autoantigen complementary peptides, or dysregulated autoantigen expression. The ANCA autoimmune response is facilitated by insufficient T-cell and B-cell regulation. A putative pathogenic mechanism for vascular inflammation begins with ANCA-induced activation of primed neutrophils and monocytes leading to activation of the alternative complement pathway, which sets in motion an inflammatory amplification loop in the vessel wall that attracts and activates neutrophils with resultant respiratory burst, degranulation, extrusion of neutrophil extracellular traps, apoptosis and necrosis. The pathogenesis of extravascular granulomatosis is less clear, but a feasible scenario proposes that a prodromal infectious or allergic condition positions primed neutrophils in extravascular tissue in which they can be activated by ANCAs in interstitial fluid to produce extravascular necrotizing injury that would initiate an innate granulomatous inflammatory response to wall off the necrotic debris.


Via Krishan Maggon
Krishan Maggon 's curator insight, August 23, 2014 9:08 PM
Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated diseaseJ. Charles Jennette& Ronald J. FalkAffiliationsContributionsCorresponding authorNature Reviews Rheumatology 10, 463–473 (2014) doi:10.1038/nrrheum.2014.103Published online 08 July 2014
Scooped by Gilbert C FAURE
August 23, 2014 3:23 AM
Scoop.it!

FDA authorizes Kronus ZnT8Ab Elisa Assay for marketing - Pharmaceutical Business Review

FDA authorizes Kronus ZnT8Ab Elisa Assay for marketing Pharmaceutical Business Review ZnT8Ab ELISA Assay works by detecting the presence of the ZnT8 autoantibody that is produced by the immune system of many type 1 diabetic patients, in a patient's...
No comment yet.
Scooped by Gilbert C FAURE
August 21, 2014 3:53 AM
Scoop.it!

FDA allows marketing of first ZnT8Ab autoantibody test to help diagnose type 1 diabetes ... - FDA.gov

FDA allows marketing of first ZnT8Ab autoantibody test to help diagnose type 1 ...
FDA.gov
Today, the U.S.
Gilbert C FAURE's insight:

diabetes

Société Francaise d'Immunologie's comment, August 22, 2014 5:38 AM
a novel anti-CAF-1 autoantibody is frequently found in patients with SLE and is a useful biomarker for diagnosis, especially in cases with CNS involvement.
Scooped by Gilbert C FAURE
August 16, 2014 9:29 AM
Scoop.it!

A highly sensitive microsphere-based assay for early detection of Type I diabetes - Science Codex

A highly sensitive microsphere-based assay for early detection of Type I diabetes Science Codex This is a concept showing microsphere based detection of an Islet Cell Autoantibody (ICA) - Glutamic Acid Decarboxylase (GAD65) using Rolling Circle...
No comment yet.
Scooped by Gilbert C FAURE
August 16, 2014 8:20 AM
Scoop.it!

Protagen AG Launches Landmark First Research Test Kit for Systemic Sclerosis - PharmiWeb.com (press release)

Protagen AG Launches Landmark First Research Test Kit for Systemic Sclerosis - PharmiWeb.com (press release) | AUTOIMMUNITY | Scoop.it
Protagen AG Launches Landmark First Research Test Kit for Systemic Sclerosis PharmiWeb.com (press release) Autoimmune dysregulation includes lymphocyte activation that causes autoantibody production aberrant cytokine and chemokine release excessive...
Gilbert C FAURE's insight:

not clear to me which biomarkers involved?

No comment yet.
Scooped by Gilbert C FAURE
July 21, 2014 2:01 PM
Scoop.it!

Trends in Autoantibody Testing - Mark H. Wener, MD

Dr. Mark Wener from the University of Washington discusses recent trends in autoantibody testing, which includes testing for such conditions as lupus, rheumatoid arthritis, and other autoimmune...
No comment yet.
Scooped by Gilbert C FAURE
July 21, 2014 4:05 AM
Scoop.it!

Epilepsy, Autoimmune Evaluation [A Test in Focus] | Mayo Medical ...

Epilepsy, Autoimmune Evaluation [A Test in Focus] | Mayo Medical ... | AUTOIMMUNITY | Scoop.it
As you consider autoimmune epilepsy in the differential diagnosis, the following may be clues leading to an autoimmune cause and use of the autoantibody profiles. Subacute onset of cognitive or other neuropsychiatric ...
No comment yet.
Scooped by Gilbert C FAURE
July 17, 2014 3:49 PM
Scoop.it!

Bristol University | School of Clinical Sciences | Islet cell autoantibodies

Bristol University | School of Clinical Sciences | Islet cell autoantibodies | AUTOIMMUNITY | Scoop.it
Nice explanation of research developments in autoantibody testing, in ppl at risk of developing type 1 #diabetes http://t.co/jhqv1JyuzJ
Gilbert C FAURE's insight:

nice review on type I diabetes immunology

No comment yet.
Scooped by Gilbert C FAURE
July 8, 2014 2:56 PM
Scoop.it!

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset | AUTOIMMUNITY | Scoop.it
Rheumatology Medical Article: Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset (Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and a...
No comment yet.
Scooped by Gilbert C FAURE
September 21, 2014 2:18 PM
Scoop.it!

Eli Lilly v Human Genome Sciences Ltd - Lexology (registration)

Eli Lilly v Human Genome Sciences Ltd - Lexology (registration) | AUTOIMMUNITY | Scoop.it
Eli Lilly v Human Genome Sciences Ltd
Lexology (registration)
HGS have received marketing approval in Europe for a belimumab-containing product (BENLYSTA®) for the treatment of active, autoantibody-positive systemic lupus erythematosus (SLE).
No comment yet.
Scooped by Gilbert C FAURE
September 18, 2014 10:45 AM
Scoop.it!

Spleen Tyrosine Kinase Inhibition Attenuates Autoantibody Production and Reverses Experimental Autoimmune GN. - Global Medical Discovery

Spleen Tyrosine Kinase Inhibition Attenuates Autoantibody Production and Reverses Experimental Autoimmune GN. - Global Medical Discovery | AUTOIMMUNITY | Scoop.it
Spleen Tyrosine Kinase Inhibition Attenuates Autoantibody Production and Reverses Experimental Autoimmune GN.:... http://t.co/hhAOL0aqwo
No comment yet.
Scooped by Gilbert C FAURE
September 8, 2014 6:14 AM
Scoop.it!

Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer’s disease, traumatic brain injury and schizophrenia - Online First - Springer

Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer’s disease, traumatic brain injury and schizophrenia - Online First - Springer | AUTOIMMUNITY | Scoop.it
Neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer disease, traumatic brain injury & schizophrenia http://t.co/SebiJdltH5
No comment yet.
Scooped by Gilbert C FAURE
August 29, 2014 2:51 PM
Scoop.it!

AQP4 autoantibody assay performance in clinical laboratory service

AQP4 autoantibody assay performance in clinical laboratory service | AUTOIMMUNITY | Scoop.it
RT @GreenJournal: AQP4 autoantibody assay performance in clinical laboratory service http://t.co/w2azoofKFj #Neurology
No comment yet.
Scooped by Gilbert C FAURE
August 23, 2014 3:30 AM
Scoop.it!

The cytokine production of peripheral blood mononuclear cells reflects the autoantibody profile of patients suffering from type 1 diabetes

The cytokine production of PBMCs reflects the autoantibody profile of patients suffering from type 1 diabetes http://t.co/ZsTheTkLcm
Gilbert C FAURE's insight:

... demonstrated a significant interaction between the patient’s autoantibody profile and mode of stimulation. This suggests that autoantigen stimulation has a different effect on different groups of patients depending on their autoantibody profile. An increased production of IL17 was found in patients with high IA2 autoantibodies compared to patients with low levels of autoantibodies and healthy controls regardless of the mode of stimulation. The titre of IA2 autoantibodies positively correlates with the proportion of Tc lymphocytes and negatively correlates with the proportion of Th lymphocytes.

No comment yet.
Scooped by Gilbert C FAURE
August 22, 2014 4:26 AM
Scoop.it!

Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus

Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus | AUTOIMMUNITY | Scoop.it
Autoantibodies to proliferating cell nuclear antigen (PCNA) are specifically, if rarely, present in systemic lupus erythematosus (SLE) patient sera. Even SLE patients lacking PCNA reactivity often...
Gilbert C FAURE's insight:

anti-PCNA

No comment yet.
Scooped by Gilbert C FAURE
August 19, 2014 5:10 AM
Scoop.it!

Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma

Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma | AUTOIMMUNITY | Scoop.it
by Catrin H. Middleton, William Irving, John F. R. Robertson, Andrea Murray, Celine B. Parsy-Kowalska, Isabel K. Macdonald, Jane McElveen, Jared Allen, Graham F. Healey, Brian J. Thomson, Stephen J. Ryder, Stefan Holdenrieder, Caroline J.
No comment yet.
Suggested by Société Francaise d'Immunologie
August 16, 2014 9:27 AM
Scoop.it!

Recombinant Human IgA1 and IgA2 Autoantibodies to Type VII Collagen Induce Subepidermal Blistering Ex Vivo [AUTOIMMUNITY]

Subepidermal autoimmune blistering dermatoses (AIBD) are prototypic autoantibody-mediated diseases.
No comment yet.
Suggested by Société Francaise d'Immunologie
July 22, 2014 3:12 PM
Scoop.it!

Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Specific Autoantibody Production in Primary Thymic Cell Cultures from Early-Onset Myasthenia Gravis Patients [CLINICAL AND HUMAN IMMU...

Bortezomib is a potent inhibitor of proteasomes currently used to eliminate malignant plasma cells in multiple myeloma patients.
No comment yet.
Scooped by Gilbert C FAURE
July 21, 2014 4:06 AM
Scoop.it!

Dementia, Autoimmune Evaluation [A Test in Focus] | Mayo Medical ...

Dementia, Autoimmune Evaluation [A Test in Focus] | Mayo Medical ... | AUTOIMMUNITY | Scoop.it
As you consider autoimmune dementia in the differential diagnosis, the following may be clues leading to an autoimmune cause and use of the autoantibody profiles. Subacute onset of cognitive or other neuropsychiatric ...
No comment yet.
Scooped by Gilbert C FAURE
July 18, 2014 4:15 AM
Scoop.it!

Paraneoplastic Jaw Dystonia and Laryngospasm With Antineuronal Nuclear Autoantibody Type 2 (Anti-Ri)

Arch Neurol. 2010;67(9):1109-1115. doi: 10.1001/archneurol.2010.209. Read the article here: http://dx.doi.org/10.1001/archneurol.2010.209.
Gilbert C FAURE's insight:

clinic of two patients published in 2010

no image of IF on cerebellum, too bad

No comment yet.
Scooped by Gilbert C FAURE
July 15, 2014 2:20 PM
Scoop.it!

Stanford researchers believe microchip holds key to diabetes diagnoses - Washington Business Journal (blog)

Stanford researchers believe microchip holds key to diabetes diagnoses - Washington Business Journal (blog) | AUTOIMMUNITY | Scoop.it
Stanford researchers believe microchip holds key to diabetes diagnoses
Washington Business Journal (blog)
What's the key here? The technical way to find a way to objectively diagnose type 1 from type 2 is to detect an autoantibody in the blood.
Société Francaise d'Immunologie's comment, July 16, 2014 8:36 AM
What we have done is use state-of-the-art technology to come up with a cheap test that uses just a drop of blood and tells people in hours if they have autoantibodies or not.

We really think this technology can be pushed to the bedside very quickly to diagnose between type 1 and type 2.

These autoantibodies are the final say in type 1 diabetes? There are basically three autoantibodies that we can measure, simultaneously, and their risk is cumulative. If you have one present, your risk is increased 10 to 20 percent; if all three are present, you have greater than 90 percent risk of developing diabetes in the future.
Société Francaise d'Immunologie's comment, July 16, 2014 8:37 AM
it is not so difficult with IF technology, and cheaper in europe?